Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Stemtech (STEK) EBT Margin (2020 - 2025)

Historic EBT Margin for Stemtech (STEK) over the last 6 years, with Q3 2025 value amounting to 95.34%.

  • Stemtech's EBT Margin rose 182100.0% to 95.34% in Q3 2025 from the same period last year, while for Sep 2025 it was 79.43%, marking a year-over-year increase of 232900.0%. This contributed to the annual value of 74.65% for FY2024, which is 357200.0% up from last year.
  • Latest data reveals that Stemtech reported EBT Margin of 95.34% as of Q3 2025, which was up 182100.0% from 42.45% recorded in Q2 2025.
  • Over the past 5 years, Stemtech's EBT Margin peaked at 1660.53% during Q3 2022, and registered a low of 1956.08% during Q2 2022.
  • For the 5-year period, Stemtech's EBT Margin averaged around 114.46%, with its median value being 75.43% (2021).
  • Examining YoY changes over the last 5 years, Stemtech's EBT Margin showed a top increase of 22464900bps in 2022 and a maximum decrease of -18806500bps in 2022.
  • Over the past 5 years, Stemtech's EBT Margin (Quarter) stood at 64.62% in 2021, then surged by 36bps to 41.32% in 2022, then tumbled by -231bps to 136.88% in 2023, then soared by 78bps to 30.19% in 2024, then crashed by -216bps to 95.34% in 2025.
  • Its EBT Margin was 95.34% in Q3 2025, compared to 42.45% in Q2 2025 and 168.05% in Q1 2025.